Pharmbiotest Poland
Broadening Our Global Footprint with a Phase I Facility in Poland
Bed Clinical Unit
0
Principal Investigators
0+
Studies Yearly
0+
Therapeutic Areas
0+
Sites Across the US
0+
Partnership Overview
Through this partnership, Revival Site Network extends its ability to support sponsors and CROs with globally aligned research operations while maintaining consistent quality and compliance standards across regions.

Revival Site Network
A leading integrated research site network specializing in serving diverse patient populations and delivering clean, query-free data. Revival integrates cutting-edge technologies to reduce risks, minimize errors, and optimize trial processes for sponsors.
30+ Principal Investigators
25+ Sites
200+ Studies/Year
12+ Therapeutic Areas
Pharmbiotest Poland
Strategically based in Europe, Pharmbiotest specializes in generic and hybrid pharmaceutical product development, providing integrated R&D, clinical, and bioanalytical services. With strong technical expertise and European regulatory experience, they serve as a dependable partner for pharma and healthcare companies.
European Regulatory Experience
Full-Service R&D
GLP-Certified Lab
CTIS Submission
Revival Site Network
A leading integrated research site network specializing in serving diverse patient populations and delivering clean, query-free data. Revival integrates cutting-edge technologies to reduce risks, minimize errors, and optimize trial processes for sponsors.
30+ Principal Investigators
25+ Sites
200+ Studies/Year
12+ Therapeutic Areas
Pharmbiotest Poland
Strategically based in Europe, Pharmbiotest specializes in generic and hybrid pharmaceutical product development, providing integrated R&D, clinical, and bioanalytical services. With strong technical expertise and European regulatory experience, they serve as a dependable partner for pharma and healthcare companies.
European Regulatory Experience
Full-Service R&D
GLP-Certified Lab
CTIS Submission
Core Capabilities
End-to-End Clinical Research Services
The Poland facility offers comprehensive, full-service solutions from formulation development through regulatory submission as well as individual service modules tailored to sponsor needs.


R&D of Generic Drugs

BA/BE Studies

Phase I Clinical Trials

Clinical Trial Documentation

GLP-Certified Bioanalytical Services

Biostatistics & Analysis

Therapeutic Drug Monitoring

Quality Assurance
Phase I Expertise
Types of Phase I Clinical Trials Conducted
The facility conducts the full spectrum of early-phase studies, offering both complete turnkey solutions and standalone service modules.
First-In-Human (FIH) Studies, Single-Ascending Dose (SAD) & Multiple-Ascending Dose (MAD)
Steady-State / Multi-Dose Drug Administration Studies
Bioavailability / Bioequivalence (BA/BE) Studies
Food-Effect Studies
Dose Escalation Studies
Drug-Drug Interaction Studies
Biosimilarity Studies
Infrastructure
State-of-the-Art Facility & Laboratory
Clinical Department
- 36-bed clinical unit (expandable)
- Examination and sample collecting rooms
- Fully equipped emergency room for urgent patient care
- Sample processing rooms
- Pharmacy room with refrigerated storage (+2 to +8°C) and monitoring alarms
- Dining room / recreation area with catering partnership
- Archive (25-year document storage)
- Emergency notification system in every room
- Generator, 6,000-liter water reserve, and uninterruptible power supplies
Bioanalytical Laboratory
- GLP-certified bioanalytical laboratory
- Analytical room equipped with Shimadzu HPLC and AB Sciex MS/MS detectors
- Sample preparation room
- Balance room
- Biosample storage: ultra-low temperature freezers (−20°C to −86°C), up to 1,500L capacity
- Purification / glassware cleaning laboratory
- Round-the-clock monitoring with automatic emergency alarms
Why This Partnership
Our Key Advantages
What sets the Revival × Pharmbiotest Poland facility apart for sponsors and CROs?

Cardiovascular & Neurological Expertise
Deep experience developing drugs in these high-demand therapeutic areas.

Full Turnkey Phase I

30+ Successful Phase I Studies

Clinical Unit & GLP Lab Under One Roof
Integrated facility minimizes sample transfer risk and turnaround time.

Complex Study Designs
Experienced in full-replicate, two-stage, and other demanding BA/BE designs.

European Regulatory Alignment

Any Complexity of Bioanalytical Methods
From ultrahigh sensitivity pg/ml assays to chiral compounds and multi-matrix analyses.



